Abstract
AbstractToday’s ability of nuclear medicine to diagnostically image almost any physiological target and to translate the obtained diagnostic information into therapeutic interventions is founded on the combination multiple individual innovations in all areas of science. Since the inception of nuclear medicine in 1941, the basic methodologies of nuclide generation, radiochemistry, imaging physics, engineering and biomedical data analysis all had to be developed de novo. This article intends to synoptically highlight individual key contributions enabling current molecular imaging and radiotherapy.
Publisher
Springer International Publishing
Reference46 articles.
1. Hertz S, Roberts A. Radioactive iodine in the study of thyroid physiology: VII. The Use of radioactive iodine therapy in hyperthyroidism. JAMA. 1946;131(2):81–6.
2. Fahey FH, Grant FD, Thrall JH. Saul Hertz, MD, and the birth of radionuclide therapy. EJNMMI Phys. 2017;4:15.
3. Seidlin SM, Marinelly LD, Oshry E. Radioactive iodine therapy; effect on functioning metastases of adenocarcinoma of the thyroid. JAMA. 1946;132(14):838–47.
4. Cassen B, Curtis L, Reed C, Libby R. Instrumentation for 131I use in medical studies. Nucleonics. 1951;9:46–50.
5. Anger HO. Scintillation camera. Rev Sci Instrm. 1958;29:27–33.